Literature DB >> 17567473

Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis.

Tatiana Kisseleva1, David A Brenner.   

Abstract

Liver fibrosis is caused by many chronic diseases. Liver injury results in activation of collagen-producing cells and excessive deposition of extracellular matrix proteins. This process is orchestrated by many cell types. Hepatocytes apoptosis and inflammatory cells trigger secretion of profibrogenic and proinflammatory cytokines, such as transforming growth factor-beta1, angiotensin II, leptin, which in turn activates hepatic stellate cells, the major source of collagen type I. This review is focused on recent progress in the study of the pathogenesis of liver fibrosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17567473     DOI: 10.1111/j.1440-1746.2006.04658.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  98 in total

1.  Osteopontin contributes to TGF-β1 mediated hepatic stellate cell activation.

Authors:  Xiao Xiao; Yi Gang; Yong Gu; Lina Zhao; Jindong Chu; Jinfeng Zhou; Xiqiang Cai; Hui Zhang; Li Xu; Yongzhan Nie; Kaichun Wu; Zhiguo Liu; Daiming Fan
Journal:  Dig Dis Sci       Date:  2012-06-04       Impact factor: 3.199

2.  Epigenetic repression of matrix metalloproteinases in myofibroblastic hepatic stellate cells through histone deacetylases 4: implication in tissue fibrosis.

Authors:  Lan Qin; Yuan-Ping Han
Journal:  Am J Pathol       Date:  2010-09-16       Impact factor: 4.307

3.  Imatinib mesylate improves liver regeneration and attenuates liver fibrogenesis in CCL4-treated mice.

Authors:  Wen-Ling Kuo; Ming-Chin Yu; Ju-Fang Lee; Chi-Neu Tsai; Tse-Ching Chen; Miin-Fu Chen
Journal:  J Gastrointest Surg       Date:  2011-11-09       Impact factor: 3.452

4.  The effect of hepatic ischemia reperfusion injury in a murine model of nonalcoholic steatohepatitis.

Authors:  Amit D Tevar; Callisia N Clarke; Rebecca Schuster; Jiang Wang; Michael J Edwards; Alex B Lentsch
Journal:  J Surg Res       Date:  2011-03-02       Impact factor: 2.192

Review 5.  Recent advances in the pathogenesis and diagnosis of liver fibrosis.

Authors:  Natalie J Török
Journal:  J Gastroenterol       Date:  2008-07-01       Impact factor: 7.527

Review 6.  Extracellular matrix and liver disease.

Authors:  Elena Arriazu; Marina Ruiz de Galarreta; Francisco Javier Cubero; Marta Varela-Rey; María Pilar Pérez de Obanos; Tung Ming Leung; Aritz Lopategi; Aitor Benedicto; Ioana Abraham-Enachescu; Natalia Nieto
Journal:  Antioxid Redox Signal       Date:  2014-01-08       Impact factor: 8.401

7.  Tumor suppressor ataxia telangiectasia mutated functions downstream of TGF-β1 in orchestrating profibrotic responses.

Authors:  Jessica M Overstreet; Rohan Samarakoon; Diana Cardona-Grau; Roel Goldschmeding; Paul J Higgins
Journal:  FASEB J       Date:  2014-12-05       Impact factor: 5.191

Review 8.  The role of TGF-β in polycystic ovary syndrome.

Authors:  Nazia Raja-Khan; Margrit Urbanek; Raymond J Rodgers; Richard S Legro
Journal:  Reprod Sci       Date:  2013-04-12       Impact factor: 3.060

9.  Inhibition of IRF3 expression reduces TGF-β1-induced proliferation of hepatic stellate cells.

Authors:  Ming-ming Ni; Tao Xu; Ya-rui Wang; Ying-hua He; Qun Zhou; Cheng Huang; Xiao-ming Meng; Jun Li
Journal:  J Physiol Biochem       Date:  2015-11-26       Impact factor: 4.158

10.  Hepatic stellate cell-targeted delivery of hepatocyte growth factor transgene via bile duct infusion enhances its expression at fibrotic foci to regress dimethylnitrosamine-induced liver fibrosis.

Authors:  Balakrishnan Chakrapani Narmada; Yuzhan Kang; Lakshmi Venkatraman; Qiwen Peng; Rashidah Binte Sakban; Bramasta Nugraha; Xuan Jiang; Ralph M Bunte; Peter T C So; Lisa Tucker-Kellogg; Hai-Quan Mao; Hanry Yu
Journal:  Hum Gene Ther       Date:  2013-05       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.